-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

906.O1.6 906-Outcomes Research—Malignant Conditions (Myeloid Disease): Real World Management And Outcome

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
survivorship, Adult, AML, Coronaviruses, SARS-CoV-2/COVID-19, ALL, Biological, Diseases, CML, CLL, Lymphoma (any), Combinations, Therapies, MDS, Study Population, Lymphoid Malignancies, Clinically relevant, Myeloid Malignancies, Quality Improvement , TKI
Saturday, December 5, 2020: 12:00 PM-1:30 PM
Malvi Bipin Savani, MD, University of Arizona Cancer Center and Raynier Devillier, Institut Paoli Calmettes
No relevant conflicts of interest to declare.
12:00 PM

Bhavik J. Pandya, PharmD1*, Cynthia Z. Qi, MBA2*, Hongbo Yang, PhD2*, Andy Garnham, MSc1*, Manasee V. Shah, MPH1* and Amer M. Zeidan, MBBS, MHS3

1Astellas Pharma Global Development, Inc., Northbrook, IL
2Analysis Group Inc., Boston, MA
3Yale University School of Medicine, New Haven, CT

12:15 PM

Gail J. Roboz, MD1, Hartmut Döhner2, Christopher Pocock, MBBS3, Hervé Dombret, MD4,5, Farhad Ravandi, MBBS6, Jun Ho Jang, MD, PhD7, Dominik Selleslag, MD8, Jiří Mayer9, Uwe M. Martens, MD10, Jane L. Liesveld, MD11, Teresa Bernal del Castillo, MD, PhD12*, Ming-Chung Wang, MD13*, Ignazia La Torre14*, Barry Skikne, MD15,16*, Keshava Kumar, PhD16*, Qian Dong, DrPH16*, Julia Braverman, PhD16*, Salem Abi Nehme, PhD16*, C.L. Beach, PharmD16* and Andrew H Wei, MBBS, PhD17,18

1Weill Medical College of Cornell University New York-Presbyterian Hospital, New York, NY
2Ulm University Hospital, Ulm, Germany
3Kent & Canterbury Hospital, Canterbury, United Kingdom
4Institut de Recherche Saint Louis, Université de Paris, Paris, France
5Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, France
6Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Hematology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
8AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium
9University Hospital Brno, Brno, Czech Republic
10Clinics Heilbronn, MOLIT Institute for Personalized Medicine, Heilbronn, Germany
11The James P Wilmot Cancer Institute, University of Rochester, Rochester, NY
12Hospital Universitario Central Asturias, Oviedo, Spain
13Division of Hematology/Oncology, Chang Gung Memorial Hospital Kaohsiung, Kaohsiung, Taiwan
14Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland
15Kansas University Medical Center, Kansas City, KS
16Bristol Myers Squibb, Princeton, NJ
17The Alfred Hospital, Melbourne, Australia
18Australian Centre for Blood Diseases, Monash University, Melbourne, Australia

12:30 PM

William A. Wood, MD, MPH1, Donna S. Neuberg, ScD2, John Colton Thompson3*, Martin S. Tallman, MD 4, Mikkael A. Sekeres, MD, MS5, Laurie H. Sehn, MD, MPH6, Kenneth Anderson, MD7, Aaron D Goldberg, MD, PhD8, Nathan A Pennell, MD, PhD9*, Charlotte M. Niemeyer, MD10, Emily Tucker, MS11*, Kathleen Hewitt, DNP, CPHQ, AACC, RN12*, Robert M Plovnick, MD, MS12 and Lisa K. Hicks, MD, MSc13

1Division of Hematology, Department of Medicine, University of North Carolina, Chapel Hill, NC
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
3ASH Research Collaborative, Washington, DC
4Memorial Sloan-Kettering Cancer Center, New York, NY
5Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
6BC Cancer Centre for Lymphoid Cancer, University of British Columbia, vancouver, BC, Canada
7Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
8Department of Medicine, Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY
9Lung Program, Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
10University Children's Hospital, Freiburg, Germany
11ASH Research Collaborative, Washington DC, DC
12American Society of Hematology, Washington DC, DC
13Division of Hematology/Oncology, St. Michael's Hospital, Toronto, ON, Canada

12:45 PM

Ehab L. Atallah, MD1, Rodrigo Maegawa, MD2*, Dominick Latremouille-Viau, MSc3*, Carmine Rossi, PhD3*, Annie Guerin, MSc3* and Pallavi Patwardhan, PhD2*

1Medical College of Wisconsin, Wauwatosa, WI
2Novartis Pharmaceuticals Corporation, East Hanover, NJ
3Analysis Group, Inc., Montreal, QC, Canada

1:00 PM

Ivy Abraham, MD1, Garth Rauscher, PhD, MPH2*, Anand Ashwin Patel, MD3, William B Pearse, MD4, Priya Rajakumar, MD5*, Stephanie Berg, DO6, Ahmed Aleem, MD6*, Ami Dave, MD5*, Sushma Bharadwaj, MD7*, Koosha Paydary, MD7*, Maria Acevedo-Mendez1, Richard Gomez6*, Kylie Carlson6*, Stephanie B. Tsai, MD, MS6, Jessica K. Altman, MD4, Wendy Stock, MD3, John G. Quigley1, Maryam Zia, MD7*, Melissa L. Larson, MD5 and Irum Khan, MD8

1Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
2Division of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, IL
3Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL
4Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
5Division of Hematology, Oncology and Stem Cell Transplant, Rush University Medical Center, Chicago, IL
6Division of Hematology and Oncology, Loyola University Medical Center, Maywood, IL
7Division of Hematology and Oncology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
8Division of Hematology and Oncology, University of Illinois, Chicago, IL

1:15 PM

Pamela C Egan, MD1,2, Emmanuelle Belanger, PhD3*, Orestis A. Panagiotou, MD, PhD4*, Vinay B Rao5*, Aryeh Pelcovits, MD5, Thomas W. LeBlanc, MD, MA, MS6 and Adam J Olszewski, MD4

1Alpert Medical School of Brown University, Providence, RI
2Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI
3Center for Gerontology and Health Care Research, Brown University School of Public Health, Providence, RI
4Brown University, Providence, RI
5Warren Alpert Medical School of Brown University, Providence, RI
6Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Hillsborough, NC

*signifies non-member of ASH